Page 4 - Nick Eisinger News Today

5 Min Read LONDON (Reuters) - A surge in emerging markets linked to the success of COVID-19 vaccines may not fully reflect the challenges of delivering scarce supplies to some of the world’s poorest countries, suggesting a bumpy 2021 for investors in the asset class. FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" are placed on dry ice in this illustration taken, December 5, 2020. REUTERS/Dado Ruvic/Illustration The vaccine rollout is already shaping up to be the investment theme of...

A surge in emerging markets linked to the success of COVID-19 vaccines may not fully reflect the challenges of delivering scarce supplies to some of the world's poorest countries, suggesting a bumpy 2021 for investors in the asset class.